Handa Pharmaceuticals, Inc. (TPEX:6620)

Handa Pharmaceuticals Statistics

Total Valuation

TPEX:6620 has a market cap or net worth of TWD 12.79 billion. The enterprise value is 11.00 billion.

Market Cap	12.79B
Enterprise Value	11.00B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	Jul 2, 2025

Share Statistics

TPEX:6620 has 158.31 million shares outstanding. The number of shares has increased by 4.73% in one year.

Current Share Class	158.31M
Shares Outstanding	158.31M
Shares Change (YoY)	+4.73%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.45%
Owned by Institutions (%)	1.28%
Float	102.57M

Valuation Ratios

The trailing PE ratio is 24.12.

PE Ratio	24.12
Forward PE	n/a
PS Ratio	15.40
PB Ratio	4.10
P/TBV Ratio	5.91
P/FCF Ratio	26.11
P/OCF Ratio	25.71
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.80, with an EV/FCF ratio of 22.46.

EV / Earnings	23.27
EV / Sales	13.24
EV / EBITDA	25.80
EV / EBIT	26.43
EV / FCF	22.46

Financial Position

The company has a current ratio of 8.72, with a Debt / Equity ratio of 0.01.

Current Ratio	8.72
Quick Ratio	8.49
Debt / Equity	0.01
Debt / EBITDA	0.09
Debt / FCF	0.08
Interest Coverage	849.71

Financial Efficiency

Return on equity (ROE) is 16.10% and return on invested capital (ROIC) is 8.82%.

Return on Equity (ROE)	16.10%
Return on Assets (ROA)	8.07%
Return on Invested Capital (ROIC)	8.82%
Return on Capital Employed (ROCE)	13.06%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.26
Inventory Turnover	n/a

Taxes

In the past 12 months, TPEX:6620 has paid 6.43 million in taxes.

Income Tax	6.43M
Effective Tax Rate	1.34%

Stock Price Statistics

The stock price has decreased by -23.24% in the last 52 weeks. The beta is 0.59, so TPEX:6620's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	-23.24%
50-Day Moving Average	81.12
200-Day Moving Average	73.98
Relative Strength Index (RSI)	44.49
Average Volume (20 Days)	231,902

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6620 had revenue of TWD 830.67 million and earned 472.74 million in profits. Earnings per share was 3.35.

Revenue	830.67M
Gross Profit	829.50M
Operating Income	418.06M
Pretax Income	479.17M
Net Income	472.74M
EBITDA	421.12M
EBIT	418.06M
Earnings Per Share (EPS)	3.35

Balance Sheet

The company has 1.83 billion in cash and 40.10 million in debt, giving a net cash position of 1.79 billion or 11.30 per share.

Cash & Cash Equivalents	1.83B
Total Debt	40.10M
Net Cash	1.79B
Net Cash Per Share	11.30
Equity (Book Value)	3.12B
Book Value Per Share	22.19
Working Capital	1.86B

Cash Flow

In the last 12 months, operating cash flow was 497.60 million and capital expenditures -7.77 million, giving a free cash flow of 489.84 million.

Operating Cash Flow	497.60M
Capital Expenditures	-7.77M
Free Cash Flow	489.84M
FCF Per Share	3.09

Margins

Gross margin is 99.86%, with operating and profit margins of 50.33% and 56.91%.

Gross Margin	99.86%
Operating Margin	50.33%
Pretax Margin	57.68%
Profit Margin	56.91%
EBITDA Margin	50.70%
EBIT Margin	50.33%
FCF Margin	58.97%

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 1.86%.

Dividend Per Share	1.50
Dividend Yield	1.86%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	44.98%
Buyback Yield	-4.73%
Shareholder Yield	-2.90%
Earnings Yield	3.70%
FCF Yield	3.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6620 has an Altman Z-Score of 30.43 and a Piotroski F-Score of 4.

Altman Z-Score	30.43
Piotroski F-Score	4